SCHEMBL5222384

SCHEMBL5222384

CS(=O)(=O)CNc1cc(C(=O)O)cc(N2CCCC2=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
HPGD P15428 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
CTSD P07339 10/20 0.46
BACE1 P56817 10/20 0.46
BACE2 Q9Y5Z0 10/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GAA P10253 1/20 0.45
TP53 P04637 1/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5218016 0.86 ALDH1A1 (0.46) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5219440 0.86 CTSD (0.58) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5224476 0.85 ALDH1A1 (0.52) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5221415 0.84 ALDH1A1 (0.51) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5222224 0.84 ALDH1A1 (0.51) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5221127 0.84 CTSD (0.56) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5221530 0.83 ALDH1A1 (0.50) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5220114 0.83 CTSD (0.53) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5221595 0.82 USP2 (0.49) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5217257 0.82 ALDH1A1 (0.50) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed